See More

ÐÏࡱá > þÿ ; = þÿÿÿ : ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿì¥Á € ø¿ ¬ bjbjöàöà 4 ”Š ”Š  ÿÿ ÿÿ ÿÿ · ö ö : : : : : ÿÿÿÿ N N N N j N " 0 v R È È È È £ £ £ ‰ ‹ ‹ ‹ ‹ ‹ ‹ $ R ¢ ô P ¯ - : £ £ £ £ £ ¯ : : È È Û Ü Ý Ý Ý £ : È : È ‰ Ý £ ‰ Ý Ý Ý È ÿÿÿÿ Щ´­ZÎ N Á Ý u ò 0 " Ý D Á D Ý Ý D : ñ „ £ £ Ý £ £ £ £ £ ¯ ¯ Ý £ £ £ " £ £ £ £ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ D £ £ £ £ £ £ £ £ £ ö : Supplementary Materials and Methods Immunofluorescence Immunofluorescence microscopy was performed on cells grown on coverslips as described ADDIN EN.CITE ADDIN EN.CITE.DATA (Franchitto et al., 2008). For immunostaining of RAD51 cells were incubated at RT for 2h with a rabbit polyclonal anti-RAD51 (Calbiochem) in 1% BSA/PBS. Specie-specific Texas Red-conjugated secondary antibodies (Jackson Immunoresearch) were applied for 1h at RT, followed by counterstaining with 0.5 ¼g / m l D A P I i n D A B C O . F o r e a c h t i m e p o i n t , a t l e a s t 2 0 0 n u c l e i w e r e e x a m i n e d b y t w o i n d e p e n d e n t i n v e s t i g a t o r s a n d f o c i w e r e s c o r e d a t 6 0 × . O n l y n u c l e i s h o w i n g m o r e t h a n f i v e b r i g h t f o c i w e r e c o u n t e d a s p o s i t i v e . P a r a l l e l s a m p l e s i n c u b a t e d w i t h e i t h e r t h e a p propriate normal serum or only with the secondary antibody confirmed that the observed fluorescence pattern was not attributable to artifacts. Coverslips were analysed through a microscope (Leica) equipped with a charge-coupled device camera (Photometrics). Images were acquired as greyscale files using the Methaview software (MDS Analytical Technologies) and then processed using Photoshop (Adobe). Evaluation of S phase cells To quantify S phase cells, GM01604 were pulse labeled for 30min with 30mg/ml BrdU and then samples were processed for immunodetection of BrdU incorporation essentially as described previously ADDIN EN.CITE Pichierri20012842(Pichierri et al., 2001)2842284217Pichierri, PietroFranchitto, AnnapaolaMosesso, PasqualePalitti, FabrizioMolecolare, CitogeneticaWerner ’ s Syndrome Protein Is Required for Correct Recovery after Replication Arrest and DNA Damage Induced in S-Phase of Cell CycleMolecular Biology of the CellMolecular Biology of the Cell2412-2421122001(Pichierri et al., 2001). For each time point, at least 500 interphase cells were scored to evaluate the percentage of labeled nuclei. Only nuclei displaying more or less uniform BrdU labeling in the entire volume were considered to be actively replicating. The percentage of cells undergoing DNA synthesis at each time point was calculated as a fraction of the treated cells versus untreated controls. Cell cycle analysis by flow cytometry GM01604 cells were transfected with siRNAs directed against GFP (control) or against MUS81 (siMUS81), then synchronized in G1/S by starvation in DMEM 0,1% FBS for 48h followed by 24h of release in DMEM 15% FBS. Then cells were treated with 400nM UCN-01 and/or for 6h with 2mM HU prior to be recovered for indicated time. Samples were collected and processed for flow cytometry as described ADDIN EN.CITE ADDIN EN.CITE.DATA (Franchitto et al., 2008) and data analysed with CellQuest software. Site-directed mutagenesis The T309A and T309D mutations were generated using the Stratagene XLII mutagenesis kit, according to the manufacturer’s directions. Briefly, mutations were introduced with specific mutagenic primer pairs and using the a plasmid for expression of the T7-tagged wild-type RAD51 ORF in human cells as template. The presence of the desired mutations and absence of unwanted DNA changes was confirmed by sequencing. # $ % 8 9   Ÿ   ´ µ · Ð Ñ Ó é 6 @ H — ¸ Ä  ’ ® É òâÙÍ·«£«£”«‰«·~£~s£~h£~£~£~£\Q h}hš hÈs mH sH hL4£ hÈs 5mH sH h%&